Home | Molecular Cancer Therapeutics

Advertisement

Read the August 2017 Issue!
About the cover: From "Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas," by King, et al.
Editor's Pick: Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas
Amanda R. King, et al.
U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts
Ashley T. Tsang, et al.
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody–Drug Conjugate Targeting 5T4
Jay Harper, et al.

From the Current Issue

Small Molecule Therapeutics | AuthorChoice

U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts

Ashley T. Tsang, Crissy Dudgeon, Lan Yi, Xin Yu, Rafal Goraczniak, Kristen Donohue, Samuel Kogan, Mark A. Brenneman, Eric S. Ho, Samuel I. Gunderson and Darren R. Carpizo

Mol Cancer Ther August 1 2017 16 (8) 1445-1455; DOI:10.1158/1535-7163.MCT-16-0867
Large Molecule Therapeutics

Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis

Sheng Zhang, Fei Liang, Ji Zhu and Qiang Chen

Mol Cancer Ther August 1 2017 16 (8) 1588-1595; DOI:10.1158/1535-7163.MCT-17-0155
Cancer Biology and Signal Transduction

Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma

Clare E. Weeden, Aliaksei Z. Holik, Richard J. Young, Stephen B. Ma, Jean-Marc Garnier, Stephen B. Fox, Phillip Antippa, Louis B. Irving, Daniel P. Steinfort, Gavin M. Wright, Prudence A. Russell, Matthew E. Ritchie, Christopher J. Burns, Benjamin Solomon and Marie-Liesse Asselin-Labat

Mol Cancer Ther August 1 2017 16 (8) 1610-1622; DOI:10.1158/1535-7163.MCT-17-0174

See the Table of Contents

Recent Reviews

Review

New B7 Family Checkpoints in Human Cancers

Ling Ni and Chen Dong

Mol Cancer Ther July 1 2017 16 (7) 1203-1211; DOI:10.1158/1535-7163.MCT-16-0761
Reviews

The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target

Melanie A. Blevins, Mingxia Huang and Rui Zhao

Mol Cancer Ther June 1 2017 16 (6) 981-990; DOI:10.1158/1535-7163.MCT-16-0592
Reviews

FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions

Maria Larrosa-Garcia and Maria R. Baer

Mol Cancer Ther June 1 2017 16 (6) 991-1001; DOI:10.1158/1535-7163.MCT-16-0876
Reviews

The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma

Antonio Ahn, Aniruddha Chatterjee and Michael R. Eccles

Mol Cancer Ther June 1 2017 16 (6) 1002-1009; DOI:10.1158/1535-7163.MCT-16-0535